Crossmark

Prognostic value of modified Erasmus Guillaiun Barre’ syndrome outcome score (mEGOS) in an Italian cohort of patients: Challenges, insights and limitations

Crossref DOI link: https://doi.org/10.1007/s10072-026-09069-2

Published Online: 2026-05-25

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mazzoli, Marco

Ariatti, Alessandra

Benuzzi, Francesca

Gozzi, Manuela

Bastia, Elisabetta

Agnoletto, Virginia

Marchioni, Alessandro

Valzania, Franco

Galassi, Giuliana https://orcid.org/0000-0002-8775-0415
License Information

Text and Data Mining valid from 2026-05-25

Version of Record valid from 2026-05-25
More Information

Article History

Received: 23 October 2025

Accepted: 23 April 2026

First Online: 25 May 2026

Declarations

:

: The protocol of GBS was approved by the Institutional Ethical Committee (N° N43/2022.)

: All the co-authors (MM, AA, FB, MG, EB,VF, AM,FV) and myself Giuliana Galassi, MD have no financial disclosure and conflict of interest.

Document is current

Any future updates will be listed below